Cargando…

Obeticholic acid ameliorates obesity and hepatic steatosis by activating brown fat

Obeticholic acid (OCA) is exemplified as a potent drug for treating primary biliary cirrhosis and nonalcoholic fatty liver disease by inhibiting bile acid synthesis. However, it remains unclear whether the effect of OCA is mediated by the function of brown adipose tissue (BAT). In the present study,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hanlin, Dong, Meng, Liu, Xiaomeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311225/ https://www.ncbi.nlm.nih.gov/pubmed/34345273 http://dx.doi.org/10.3892/etm.2021.10423

Ejemplares similares

Fluvastatin Sodium Ameliorates Obesity through Brown Fat Activation
por: Yin, Na, et al.
Publicado: (2019)

Obeticholic acid ameliorates severity of Clostridioides difficile infection in high fat diet-induced obese mice
por: Jose, Shinsmon, et al.
Publicado: (2020)

Obeticholic acid treatment ameliorates the cardiac dysfunction in NASH mice
por: Liu, Szu-Yu, et al.
Publicado: (2022)

The Edible Brown Seaweed Sargassum horneri (Turner) C. Agardh Ameliorates High-Fat Diet-Induced Obesity, Diabetes, and Hepatic Steatosis in Mice
por: Murakami, Shigeru, et al.
Publicado: (2021)

l-Fucose ameliorates high-fat diet-induced obesity and hepatic steatosis in mice
por: Wu, Guangyan, et al.
Publicado: (2018)

Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice
por: Jouihan, Hani, et al.
Publicado: (2017)

miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice
por: Rodrigues, Pedro M, et al.
Publicado: (2017)

miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice
por: Rodrigues, Pedro M, et al.
Publicado: (2017)

Obeticholic acid ameliorates dyslipidemia but not glucose tolerance in mouse model of gestational diabetes
por: McIlvride, Saraid, et al.
Publicado: (2019)

Correction to: l-Fucose ameliorates high-fat diet-induced obesity and hepatic steatosis in mice
por: Wu, Guangyan, et al.
Publicado: (2020)

Obeticholic acid for primary biliary cholangitis
Publicado: (2020)

Obeticholic Acid for Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

FGF2 disruption enhances thermogenesis in brown and beige fat to protect against adiposity and hepatic steatosis
por: Li, Haifang, et al.
Publicado: (2021)

Germinated brown rice ameliorates obesity in high-fat diet induced obese rats
por: Lim, See Meng, et al.
Publicado: (2016)

Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury
por: Ferrigno, Andrea, et al.
Publicado: (2020)

Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice
por: Luo, Li, et al.
Publicado: (2019)

Umbelliferone Ameliorates Hepatic Steatosis and Lipid-Induced ER Stress in High-Fat Diet-Induced Obese Mice
por: Park, Na Won, et al.
Publicado: (2023)

Bile Acid–Mediated Activation of Brown Fat Protects From Alcohol-Induced Steatosis and Liver Injury in Mice
por: Fan, Mingjie, et al.
Publicado: (2021)

Metabolomic Study of High-Fat Diet-Induced Obese (DIO) and DIO Plus CCl(4)-Induced NASH Mice and the Effect of Obeticholic Acid
por: Zhu, Nanlin, et al.
Publicado: (2021)

Clarification of Obeticholic Acid Dosing: Response to “Occurrence of Jaundice Following Simultaneous Ursodeoxycholic Acid Cessation and Obeticholic Acid Initiation” by Quigley et al.
por: Feng, Cynthia
Publicado: (2018)

Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell models
por: Zhang, Yuanyuan, et al.
Publicado: (2017)

Treatment of Nonalcoholic Steatohepatitis by Obeticholic Acid: Current Status
por: Roy, Partho Pratik, et al.
Publicado: (2022)

Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
por: Tølbøl, Kirstine S, et al.
Publicado: (2018)

Aquaporin-8 ameliorates hepatic steatosis through farnesoid X receptor in obese mice
por: Xiang, Minqi, et al.
Publicado: (2023)

Aquaporin-8 ameliorates hepatic steatosis through farnesoid X receptor in obese mice
por: Xiang, Minqi, et al.
Publicado: (2023)

Prebiotic Xylo-Oligosaccharides Ameliorate High-Fat-Diet-Induced Hepatic Steatosis in Rats
por: Lensu, Sanna, et al.
Publicado: (2020)

Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats
por: Palladini, Giuseppina, et al.
Publicado: (2022)

Ginsenoside Rb2 Alleviates Obesity by Activation of Brown Fat and Induction of Browning of White Fat
por: Hong, Yilian, et al.
Publicado: (2019)

Obeticholic Acid Induces Hepatoxicity Via FXR in the NAFLD Mice
por: Lin, Chuangzhen, et al.
Publicado: (2022)

Compound dark tea ameliorates obesity and hepatic steatosis and modulates the gut microbiota in mice
por: Qu, Jianyu, et al.
Publicado: (2023)

Sodium glucose cotransporter 2 inhibitor dapagliflozin depressed adiposity and ameliorated hepatic steatosis in high-fat diet induced obese mice
por: Han, Tuo, et al.
Publicado: (2021)

Brown Fat Dnmt3b Deficiency Ameliorates Obesity in Female Mice
por: Li, Fenfen, et al.
Publicado: (2021)

Co-administration of obeticholic acid and simvastatin protects against high-fat diet-induced non-alcoholic steatohepatitis in mice
por: Li, Wen-Cong, et al.
Publicado: (2021)

Betaine in ameliorating alcohol-induced hepatic steatosis
por: Rehman, Aisha, et al.
Publicado: (2021)

Obeticholic acid and ferrostatin-1 differentially ameliorate non-alcoholic steatohepatitis in AMLN diet-fed ob/ob mice
por: Li, Shengjie, et al.
Publicado: (2022)

Leaf powder supplementation of Senna alexandrina ameliorates oxidative stress, inflammation, and hepatic steatosis in high-fat diet-fed obese rats
por: Nayan, Shariful Islam, et al.
Publicado: (2021)

FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
por: Verbeke, Len, et al.
Publicado: (2016)

Upregulation of adiponectin by Ginsenoside Rb1 contributes to amelioration of hepatic steatosis induced by high fat diet
por: Li, Yaru, et al.
Publicado: (2022)

Metformin ameliorates hepatic steatosis and improves the induction of autophagy in HFD-induced obese mice
por: Li, Min, et al.
Publicado: (2017)

Activation of FXR by obeticholic acid induces hepatic gene expression of SR-BI through a novel mechanism of transcriptional synergy with the nuclear receptor LXR
por: Dong, Bin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_96iihqa1dvvlg4ant16nleo07b